922 related articles for article (PubMed ID: 26019446)
1. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
2. The IL-23/IL-17 pathway in inflammatory bowel disease.
Geremia A; Jewell DP
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
[TBL] [Abstract][Full Text] [Related]
3. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
[TBL] [Abstract][Full Text] [Related]
4. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
5. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
6. IL-23/IL-17 axis in IBD.
Sarra M; Pallone F; Macdonald TT; Monteleone G
Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
[TBL] [Abstract][Full Text] [Related]
7. Th17 plasticity and its changes associated with inflammatory bowel disease.
Ueno A; Ghosh A; Hung D; Li J; Jijon H
World J Gastroenterol; 2015 Nov; 21(43):12283-95. PubMed ID: 26604637
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
9. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-23/Th17 pathways and inflammatory bowel disease.
Abraham C; Cho J
Inflamm Bowel Dis; 2009 Jul; 15(7):1090-100. PubMed ID: 19253307
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-23 axis in intestinal inflammation.
Ahern PP; Izcue A; Maloy KJ; Powrie F
Immunol Rev; 2008 Dec; 226():147-59. PubMed ID: 19161422
[TBL] [Abstract][Full Text] [Related]
13. IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF
Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
15. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
Troncone E; Marafini I; Pallone F; Monteleone G
Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
[TBL] [Abstract][Full Text] [Related]
16. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
17. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K; Beikler T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in IBD pathogenesis: genetics and immunobiology.
Shih DQ; Targan SR; McGovern D
Curr Gastroenterol Rep; 2008 Dec; 10(6):568-75. PubMed ID: 19006613
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.
Hildner K; Punkenburg E; Abendroth B; Neurath MF
Dig Dis; 2016; 34 Suppl 1():40-7. PubMed ID: 27548324
[TBL] [Abstract][Full Text] [Related]
20. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
